Science Explorer Back to mapMap
Discussion
Researcher · Reata Pharmaceuticals (United States) · United States

Colin J. Meyer

Colin J. Meyer publishes mostly in Molecular Biology, Nephrology and Oncology, on topics such as Genomics, phytochemicals, and oxidative stress, Genetic Neurodegenerative Diseases and Advanced Glycation End Products research.

OpenAlex
World rank
#263,888
of 7,710,434 ranked researchers
Rank in United States
#96,637
of 1,627,098
Works
124
Citations
6.9k
Citations per work
55.5
h-index
41
i10-index 56Top 6.7% in Molecular Biology
Colin J. Meyer

What does Colin J. Meyer research?

Colin J. Meyer's work is mostly in Biochemistry, Genetics and Molecular Biology (35%), Medicine (14%), Neuroscience (4%).

Everything else: 58 works · 47.1% of their workLife Sciences: 48 works · 38.5% of their workBiochemistry, Genetics and Molecular Biology: 43 works · 35.0% of their workMolecular Biology: 38 works · 30.8% of their workClinical Biochemistry: 5 works · 4.2% of their workNeuroscience: 4 works · 3.5% of their workCellular and Molecular Neuroscience: 4 works · 3.5% of their workHealth Sciences: 18 works · 14.4% of their workMedicine: 18 works · 14.4% of their workNephrology: 7 works · 5.4% of their workCardiology and Cardiovascular Medicine: 6 works · 4.5% of their workOncology: 6 works · 4.5% of their workTHEIR WORKColin J. Meyer124works
Life Sciences38%Health Sciences14%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else5847.1%
    1. Biochemistry, Genetics and Molecular Biology4335.0%
    2. Neuroscience43.5%
    1. Medicine1814.4%
  1. 1Molecular Biology31% of their works
  2. 2Nephrology5% of their works
  3. 3Oncology4% of their works
  4. 4Cardiology and Cardiovascular Medicine4% of their works
  5. 5Clinical Biochemistry4% of their works
  6. 6Cellular and Molecular Neuroscience4% of their works

Research topics

Which keywords describe Colin J. Meyer's research?

The keywords of their largest research topics: Inflammation, Oxidative Stress, Cancer, Keap1-Nrf2-ARE Pathway, Nrf2, Mitochondrial Dysfunction, Huntington's Disease and Protein Aggregation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Inflammation644 topics
  2. Oxidative Stress644 topics
  3. Cancer553 topics
  4. Keap1-Nrf2-ARE Pathway411 topic
  5. Nrf2411 topic
  6. Mitochondrial Dysfunction182 topics
  7. Huntington's Disease101 topic
  8. Protein Aggregation101 topic
  9. Advanced Glycation End Products91 topic
  10. Cell Adhesion91 topic
  11. HMGB191 topic
  12. Integrins91 topic
  13. Chronic Kidney Disease81 topic
  14. Glomerular Filtration Rate81 topic
  15. Mitochondria81 topic
  16. Reactive Oxygen Species81 topic
  17. Glutathione Transferases61 topic
  18. Superoxide Dismutase61 topic
  19. NF-?B51 topic
  20. Signaling51 topic

Where does Colin J. Meyer work?

Colin J. Meyer's main affiliation in the publication record is Reata Pharmaceuticals (United States), United States.

How many publications and citations does Colin J. Meyer have?

OpenAlex counts 124 works and 6,879 citations for Colin J. Meyer, an h-index of 41, ranking #263,888 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Colin J. Meyer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.